BioWorld MedTech

Dec. 5, 2018

Grail looks to bag SUMMIT, unveils plans for massive U.K. cancer study

Menlo Park, Calif.-based Grail Inc. has caused a stir with its focus on the early detection of cancer. Now, the company is reporting plans to kick off the massive SUMMIT study early next year. Read More

Supreme Court steps in as grammar police for AIA's on-sale bar

Germany weak in digital health, far behind Estonia, Canada, Denmark, Israel

Advisory panel says there is a need for 'bigger and longer' PAS for Optimizer

Study finds cryoablation an effective, in-office treatment for low-risk breast cancer

Israel's E-Motion Medical wins CE mark for novel motility stimulation therapy

Product briefs

Other news to note

Daily M&A

Regulatory front

Appointments and advancements

Financings

BioWorld MedTech's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for Feb. 11, 2025.

Illustration of SCAN in Parkinson’s vs healthy subcortex

SCAN is core circuit affected in Parkinson’s disease

BioWorld Science

Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...

Astellas’ ASP-2246 shows promise in stroke management

BioWorld Science

Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...

News in brief

BioWorld Asia

BioWorld Asia briefs for Feb. 10, 2026

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...